Patents Assigned to University of Turku
  • Isoform specific anti-HER4 antibodies
    Patent number: 9963517
    Abstract: Compositions and methods useful for detecting and treating cancers which express the HER4 JM-a isoform are disclosed.
    Type: Grant
    Filed: November 19, 2015
    Date of Patent: May 8, 2018
    Assignees: Genentech, Inc., University of Turku
    Inventors: Mark X. Sliwkowski, Klaus Elenius, Maija Hollmen
  • ISOFORM SPECIFIC ANTI-HER4 ANTIBODIES
    Publication number: 20160075798
    Abstract: Compositions and methods useful for detecting and treating cancers which express the HER4 JM-a isoform are disclosed.
    Type: Application
    Filed: November 19, 2015
    Publication date: March 17, 2016
    Applicants: UNIVERSITY OF TURKU, GENENTECH, INC.
    Inventors: Mark X. Sliwkowski, Klaus Elenius, Maija Hollmen
  • Immunoassay
    Patent number: 7638292
    Abstract: A method for detection and/or quantification of cardiac troponin I (cTnI) in a sample derived from an individual's blood, the method being based on a sandwich immunoassay employing at least two capture antibodies and at least one tracer antibody, in which a first capture antibody is directed to the N-terminal part of cTnI, to the C-terminal part of cTnI or to the part of the cTnI midfragment, which is slightly affected by the interfering factor, and a second capture antibody is directed to another of these parts, and a tracer antibody is directed to the N-terminal part of cTnI, to the C-terminal part of cTnI or to TnC, which is complexed with cTnI.
    Type: Grant
    Filed: November 13, 2007
    Date of Patent: December 29, 2009
    Assignee: University of Turku
    Inventors: Susann Eriksson, Kim Pettersson
  • Immunoassay
    Patent number: 7348157
    Abstract: A method for detection and/or quantification of cardiac troponin I (cTnI) in a sample derived from an individual's blood, the method being based on a sandwich immunoassay employing at least two capture antibodies and at least one tracer antibody, in which a first capture antibody is directed to the N-terminal part of cTnI, to the C-terminal part of cTnI or to the part of the cTnI midfragment, which is slightly affected by the interfering factor, and a second capture antibody is directed to another of these parts, and a tracer antibody is directed to the N-terminal part of cTnI, to the C-terminal part of cTnI or to TnC, which is complexed with cTnI.
    Type: Grant
    Filed: April 7, 2004
    Date of Patent: March 25, 2008
    Assignee: University of Turku
    Inventors: Susann Eriksson, Kim Pettersson